Navigating 5 Analyst Ratings For Thermo Fisher Scientific
Portfolio Pulse from Benzinga Insights
Thermo Fisher Scientific (NYSE:TMO) received mixed analyst ratings over the last quarter, with 2 bullish, 2 somewhat bullish, and 1 indifferent rating. The average 12-month price target increased to $630.4, reflecting a 1.35% rise. Analysts' actions included both raises and lowers in ratings and price targets.
July 25, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Thermo Fisher Scientific received mixed analyst ratings, with 2 bullish, 2 somewhat bullish, and 1 indifferent rating. The average 12-month price target increased to $630.4, reflecting a 1.35% rise. Analysts' actions included both raises and lowers in ratings and price targets.
The mixed analyst ratings and the slight increase in the average 12-month price target suggest a cautiously optimistic outlook for Thermo Fisher Scientific. The actions taken by analysts, including both raises and lowers in ratings and price targets, indicate a nuanced view of the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100